The fibrotic microenvironment enriched in TGF-β, IL-6, and characterized by increased extracellular matrix stiffness facilitates EMT, angiogenesis, and immune evasion, thereby fostering a tumor-promoting niche. This evidence concerns the gene TGFB1 and neoplasm.